Abstract:Objective This study aimed to examine the clinical distinctions among patients diagnosed with autoimmune encephalitis (AE) based on the presence or absence of cerebrospinal fluid (CSF) oligoclonal bands (OCBs). Additionally, it sought to explore the relationship between OCBs and the severity and prognosis of autoimmune encephalitis. Methods A retrospective analysis was conducted on 94 patients diagnosed with AE at the People’s Hospital of Zhengzhou University between October 2016 and June 2022. The patients were divided into OCB-positive and OCB-negative groups based on CSF-OCBs. Patient severity at admission was assessed utilizing the Clinical Assessment Scale for Autoimmune Encephalitis (CASE) and the modified Rankin scale (mRS). Additionally, some oligoclonal-positive patients underwent dynamic longitudinal analysis of cerebrospinal fluid test indices. The mRS score was ultimately employed to evaluate patients’ short-term prognosis (6 months) and long-term prognosis (at least 12 months) following immunotherapy. Results Of the 94 patients, 34 (36.2%) belonged to the OCB-positive group, while 60 (63.8%) belonged to the OCB-negative group. The group with anti-n-methyl-d-aspartate receptor (anti-NMDAR) encephalitis exhibited the highest rate of oligoclonal positivity at 27 (49.1%), followed by anti-aminobutyric acid B receptor (GABABR) encephalitis with 4 cases (30.8%), anti-contactin-associated protein-like 2 (CASPR2) encephalitis with 2 cases (20%), and anti-leucine-rich glioma inactivating protein 1 (LGI1) encephalitis with 1 case (6.25%). No statistically significant differences were found between the two groups regarding gender, age, prodromal symptoms, psychiatric disorders, seizures, language disorders, motor dysfunction, cognitive dysfunction, tumor incidence, and magnetic resonance imaging (MRI) abnormalities ( p > 0.05). The OCB-positive group exhibited higher rates of autonomic dysfunction, intensive care unit (ICU) admission, CSF leukocytes, and IgG index compared to the OCB-negative group ( p < 0.05). Additionally, the OCB-positive group had significantly higher median CASE and mRS scores prior to immunotherapy than the OCB-negative group ( p < 0.001 and p < 0.001). Furthermore, in both short-term follow-up and long-term follow-up, the OCB-positive group had a significantly lower proportion of patients with a favorable prognosis compared to the OCB-negative group (50% vs. 71.7, 61.8% vs. 83.3%; p = 0.036, p = 0.002). Conclusion Autonomic dysfunction, ICU admission, leukocytes in the cerebrospinal fluid, and elevated IgG index are more commonly observed in OCB-positive patients. OCB-positivity has also been linked to the severity and prognosis of AE, making it a potential biomarker. Initial OCB testing aids clinicians in identifying potentially critically ill patients early and monitoring disease progression, thereby optimizing clinical treatment decisions.

Cognitive impairments in autoimmune encephalitis: the role of autoimmune antibodies and oligoclonal bands

Comparing clinical features, severity and prognosis of autoimmune encephalitis and with and without oligoclonal bands

Cerebrospinal Fluid Findings in Patients With Autoimmune Encephalitis-A Systematic Analysis

Antibodies Associated With Autoimmune Encephalitis in Patients With Presumed Neurodegenerative Dementia

Characterizing cognitive function in patients with autoimmune encephalitis: an Australian prospective study

A-280 Residual Cognitive Weaknesses in a Case of Treated Seronegative Autoimmune Encephalitis

Prospective Quantification of CSF Biomarkers in Antibody-Mediated Encephalitis

Peripheral monocytes and soluble biomarkers in autoimmune encephalitis

Autoimmune encephalitis in Israeli children – A retrospective nationwide study

Converging synaptic and network dysfunctions in distinct autoimmune encephalitis

Cerebrospinal fluid soluble CD27 is a sensitive biomarker of inflammation in autoimmune encephalitis

Predicting the future of autoimmune encephalitides

Memory function in autoimmune encephalitis: a cross-sectional prospective study utilising multiple memory paradigms

Magnetic Resonance Imaging Characteristics of LGI1-Antibody and CASPR2-Antibody Encephalitis

Imaging of autoimmune encephalitis – Relevance for clinical practice and hippocampal function

Clinical manifestations and immunomodulatory treatment experiences in psychiatric patients with suspected autoimmune encephalitis: a case series of 91 patients from Germany

A clinical approach to diagnosis of autoimmune encephalitis

Ultrahigh frequencies of peripherally matured LGI1- and CASPR2-reactive B cells characterize the cerebrospinal fluid in autoimmune encephalitis

Kappa index in the diagnostic work-up of autoimmune encephalitis

Linking brain networks to cognition with magnetoencephalography in paediatric autoimmune encephalitis

Clinical characteristics, immunological alteration and distinction of MOG-IgG-associated disorders and GFAP-IgG-associated disorders